Clinical Trials on Primitive Neuroectodermal Tumor (PNET) in Japan
Total 83 results
-
Kyushu UniversityRecruitingPediatric Solid Tumors | Refractory/Relapse NeuroblastomaJapan
-
Eli Lilly and CompanyNew Approaches to Neuroblastoma Therapy Consortium (NANT); Innovative Therapies...Active, not recruitingNeuroblastomaUnited States, Spain, Australia, Belgium, Japan, France, Germany, Italy, United Kingdom
-
Novartis PharmaceuticalsCompletedMedulloblastoma | Basal Cell Carcinoma | Advanced Solid Tumor CancersTaiwan, Hong Kong, Japan
-
Y-mAbs TherapeuticsTerminatedNeuroblastoma | Leptomeningeal Metastases | CNS MetastasesUnited States, Denmark, Japan, Spain
-
Eli Lilly and CompanyRecruitingNeoplasm Metastasis | Sarcoma, EwingUnited States, Australia, Spain, Japan, France, Italy, Germany
-
Novartis PharmaceuticalsCompletedNeuroendocrine Tumors | Advanced NET of GI Origin | Advanced NET of Lung OriginUnited States, Colombia, Italy, Taiwan, United Kingdom, Belgium, Czechia, Germany, Japan, Saudi Arabia, Canada, Netherlands, Spain, Korea, Republic of, Lebanon, Austria, China, Greece, South Africa, Thailand, Hungary, Turkey, Poland, ... and more
-
Novartis PharmaceuticalsCompletedWell-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine CarcinomaUnited States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
GlaxoSmithKlineCompleted
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Keio UniversityMerck Sharp & Dohme LLC; Ohara Pharmaceutical Co., Ltd.Recruiting
-
Novartis PharmaceuticalsActive, not recruitingSomatostatin Receptor-positive Neuroendocrine TumorJapan
-
Daiichi SankyoDaiichi Sankyo, Inc.Active, not recruiting
-
Translational Research Center for Medical Innovation...Department of Nuerosurgery, Osaka Medical CollegeCompletedBrain and Central Nervous System TumorsJapan
-
Novartis PharmaceuticalsEckert & Ziegler Radiopharma GmbHRecruiting
-
Eisai Co., Ltd.Completed
-
Eisai Co., Ltd.CompletedMalignant GliomaJapan
-
HutchmedActive, not recruitingNeuroendocrine Tumors | Non-hematologic MalignancyJapan
-
Cancer Intelligence Care Systems, Inc.Stella Pharma CorporationCompletedAngiosarcoma | Malignant MelanomaJapan
-
Wakayama Medical UniversityOsaka University; Kyoto Prefectural University of Medicine; Nara Medical University and other collaboratorsCompletedPancreatic Cancer | Chronic Pancreatitis | Pancreatic Cystic Lesions | Pancreatic Neuroendocrine Tumors | Pancreatic PseudocystsJapan
-
NobelpharmaCompleted
-
Osaka UniversityMerck Sharp & Dohme LLC; ISHIHARA SANGYO KAISHA,LTD. JapanUnknownAdvanced MelanomaJapan
-
NobelpharmaCompleted
-
Bristol-Myers SquibbCompleted
-
Boehringer IngelheimRecruitingNeuroendocrine NeoplasmsUnited States, Spain, Germany, Japan
-
Bristol-Myers SquibbCompleted
-
PfizerCompletedPancreatic Neuroendocrine TumorsJapan
-
PfizerCompletedWell-differentiated Pancreatic Neuroendocrine TumorUnited States, China, Czechia, India, Japan, South Africa, Slovakia, France, Norway, Romania, Australia, Belgium, Hungary, Italy, Spain
-
Takara Bio Inc.CompletedMelanoma Stage IV | Melanoma Stage IIIJapan
-
Daiichi Sankyo Co., Ltd.Active, not recruiting
-
Novartis PharmaceuticalsTerminatedIslet Cell TumorFrance, Spain, United Kingdom, Belgium, Hungary, Turkey, Canada, Argentina, Sweden, Italy, Thailand, Germany, Netherlands, Brazil, Australia, Japan, United States, Denmark, New Zealand
-
AmgenCompletedUnresectable Stage IIIB-IV Malignant MelanomaJapan
-
EMD Serono Research & Development Institute, Inc.CompletedCarcinoma, Merkel CellUnited States, Spain, Australia, Italy, Germany, France, Japan
-
Genzyme, a Sanofi CompanyCompletedUnresectable Locally Advanced or Metastatic, Medullary Thyroid CarcinomaJapan
-
PfizerCompletedMelanoma and Metastatic Colorectal CancerUnited States, Spain, France, Japan, Australia, Switzerland, Norway
-
Novartis PharmaceuticalsTerminatedIn Escalation: All Patients With Solid Tumors and Lymphoma | In Expansion: Melanoma, Non-small Cell Lung CancerUnited States, Italy, Taiwan, Belgium, Spain, Germany, Japan
-
Novartis PharmaceuticalsCompletedAdvanced Neuroendocrine Tumors of Pancreatic OriginCanada, France, United Kingdom, Taiwan, Belgium, Spain, Netherlands, United States, Italy, Sweden, Switzerland, Thailand, Germany, Greece, Korea, Republic of, Japan, Brazil, Slovakia
-
Canadian Cancer Trials GroupEuropean Organisation for Research and Treatment of Cancer - EORTC; Trans Tasman...CompletedBrain and Central Nervous System TumorsCanada, Germany, Japan, Netherlands
-
Boehringer IngelheimRecruitingNeuroendocrine Neoplasms | Small Cell Lung Carcinoma (SCLC)Germany, Belgium, Japan, France
-
Sumitomo Pharma Co., Ltd.CompletedGlioblastoma | Diffuse Intrinsic Pontine GliomaJapan
-
Novartis PharmaceuticalsRecruitingMelanoma | Solid Tumor | High Grade Glioma | Non Small Cell Lung Cancer | Rare CancersSpain, Germany, United States, Argentina, Austria, Denmark, France, Hungary, Netherlands, China, Japan, Thailand
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedMelanomaUnited States, France, Italy, United Kingdom, Spain, Belgium, Israel, Mexico, Japan, Canada, Netherlands, Sweden, Korea, Republic of, Australia, Russian Federation, Chile, Germany, Poland, Ireland, New Zealand, Denmark, Switzerland, South Africa
-
National Cancer Center, JapanOno Pharmaceutical Co. LtdRecruitingPancreatic Cancer | Low-grade GliomaJapan
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Belgium, Canada, Spain, United Kingdom, Netherlands, Argentina, Australia, Austria, Brazil, Czechia, Denmark, France, Germany, Greece, Israel, Italy, Japan, New Zealand, Norway, Poland, Russian Federation, Sweden, Switz... and more
-
GlaxoSmithKlineTerminatedMelanomaUnited States, Australia, Spain, Taiwan, Bulgaria, Estonia, Germany, Belgium, France, Sweden, Israel, Poland, Italy, Czechia, Switzerland, Korea, Republic of, Ireland, Canada, Argentina, Netherlands, Russian Federation, Ukraine, Aus... and more
-
Bristol-Myers SquibbCompletedMelanoma | Skin CancerUnited States, Canada, Netherlands, Spain, Australia, Italy, Japan, Germany, Ireland, United Kingdom, Czechia, Switzerland, Poland, France, Greece, New Zealand
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruitingMelanoma | Cervical Cancer | Head and Neck Cancer | Gastric Cancer | Esophageal Cancer | Prostate Cancer | Bladder Cancer | Advanced Solid Tumor | Endometrial Cancer | Ovarian Carcinoma | Pancreatic CarcinomaUnited States, Japan
-
Sumitomo Pharma America, Inc.Active, not recruitingGlioblastoma Multiforme | High Grade GliomaUnited States, Japan
-
Incyte CorporationActive, not recruitingCervical Cancer | Nasopharyngeal Carcinoma | Mesothelioma | Advanced Solid Tumor | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Urothelial Carcinoma | Merkel Cell Carcinoma | HepatoCellular Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1)France, United States, Japan, Belgium, Australia
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaCanada, United States, Australia, Belgium, Brazil, Chile, France, Germany, Israel, Italy, Japan, Poland, South Africa, Spain, Switzerland, United Kingdom